{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "in-the-event-of-a", "type": "clause", "offset": [0, 17]}, {"key": "the-shares", "type": "clause", "offset": [64, 74]}, {"key": "article-ii", "type": "definition", "offset": [87, 97]}, {"key": "the-provisions-of-section", "type": "clause", "offset": [99, 124]}, {"key": "to-apply", "type": "clause", "offset": [145, 153]}, {"key": "agreement-to", "type": "definition", "offset": [178, 190]}, {"key": "all-shares", "type": "clause", "offset": [191, 201]}, {"key": "owned-by", "type": "definition", "offset": [215, 223]}, {"key": "the-stockholder", "type": "clause", "offset": [224, 239]}], "samples": [{"hash": "jQshUCGctiP", "uri": "/contracts/jQshUCGctiP#continuing-application", "label": "Stockholders' and Voting Agreement (Zion Oil & Gas Inc)", "score": 21.0, "published": true}, {"hash": "jJxT1jC2l6U", "uri": "/contracts/jJxT1jC2l6U#continuing-application", "label": "Stockholders' and Voting Agreement (Zion Oil & Gas Inc)", "score": 21.0, "published": true}, {"hash": "ixN3JjfgDN5", "uri": "/contracts/ixN3JjfgDN5#continuing-application", "label": "Stockholders' and Voting Agreement (Zion Oil & Gas Inc)", "score": 21.0, "published": true}], "size": 15, "snippet": "In the event of a Transfer by a Stockholder of less than all of the Shares pursuant to Article II, the provisions of Section 4.01 shall continue to apply during the term of this Agreement to all Shares Beneficially Owned by the Stockholder.", "hash": "4dc0d3cd6cd26c750264bd3a94d95f22", "id": 1}, {"snippet_links": [{"key": "terms-of-this-agreement", "type": "clause", "offset": [4, 27]}, {"key": "to-apply", "type": "clause", "offset": [42, 50]}, {"key": "length-of-service", "type": "clause", "offset": [124, 141]}, {"key": "to-the-executive", "type": "clause", "offset": [176, 192]}, {"key": "duties-and-responsibilities", "type": "clause", "offset": [205, 232]}, {"key": "other-terms-of-employment", "type": "clause", "offset": [263, 288]}, {"key": "changes-to-the-company", "type": "clause", "offset": [300, 322]}, {"key": "a-reorganization", "type": "clause", "offset": [338, 354]}, {"key": "plan-of-arrangement", "type": "clause", "offset": [356, 375]}, {"key": "merger-or-acquisition", "type": "definition", "offset": [396, 417]}], "samples": [{"hash": "dtFYnrHEyE", "uri": "/contracts/dtFYnrHEyE#continuing-application", "label": "Executive Employment Agreement (Lexaria Bioscience Corp.)", "score": 35.9021224976, "published": true}, {"hash": "bm5zNnImCG0", "uri": "/contracts/bm5zNnImCG0#continuing-application", "label": "Executive Employment Agreement (Lexaria Bioscience Corp.)", "score": 35.9021224976, "published": true}, {"hash": "hiowXx1xb9R", "uri": "/contracts/hiowXx1xb9R#continuing-application", "label": "Executive Employment Agreement (Lexaria Bioscience Corp.)", "score": 35.2696800232, "published": true}], "size": 4, "snippet": "The terms of this Agreement will continue to apply throughout the Executive\u2019s employment, regardless of:\na) the Executive\u2019s length of service; or\nb) any changes that may occur to the Executive\u2019s position, duties and responsibilities, compensation or benefits, or other terms of employment; or\nc) any changes to the Company as a result of a reorganization, plan of arrangement, reverse take-over, merger or acquisition.", "hash": "cf537b47a37fa04661003b1082de4946", "id": 2}, {"snippet_links": [{"key": "this-clause", "type": "clause", "offset": [18, 29]}, {"key": "full-force-and-effect", "type": "definition", "offset": [57, 78]}, {"key": "rescission-of", "type": "clause", "offset": [116, 129]}, {"key": "this-agreement", "type": "clause", "offset": [130, 144]}, {"key": "for-any-reason", "type": "clause", "offset": [146, 160]}], "samples": [{"hash": "iNZURXYGs7R", "uri": "/contracts/iNZURXYGs7R#continuing-application", "label": "Concession Agreement for the Exploration, Development and Production of Oil and Natural Gas", "score": 21.0, "published": true}, {"hash": "clvRfRaZwZE", "uri": "/contracts/clvRfRaZwZE#continuing-application", "label": "Concession Agreement for the Exploration, Development and Production of Oil and Natural Gas", "score": 21.0, "published": true}], "size": 3, "snippet": "The provisions of this Clause Thirty-One shall remain in full force and effect and shall survive the termination or rescission of this Agreement, for any reason whatsoever.", "hash": "faf388e51664e47e5faf757cd2d8d8a3", "id": 3}, {"snippet_links": [{"key": "this-contract", "type": "clause", "offset": [18, 31]}, {"key": "full-force-and-effect", "type": "definition", "offset": [48, 69]}, {"key": "sale-and-purchase-of-the-property", "type": "clause", "offset": [148, 181]}], "samples": [{"hash": "bpsIsmnEzqy", "uri": "/contracts/bpsIsmnEzqy#continuing-application", "label": "Contract for the Sale and Purchase (Life Sciences Research Inc)", "score": 18.0, "published": true}, {"hash": "2e6JR93697I", "uri": "/contracts/2e6JR93697I#continuing-application", "label": "Contract for the Sale and Purchase (Life Sciences Research Inc)", "score": 18.0, "published": true}], "size": 3, "snippet": "The provisions of this contract shall remain in full force and effect in so far as they remain to be performed and observed after completion of the sale and purchase of the Property.", "hash": "f80b03198ee37ffd3f7ce40791b4e35e", "id": 4}, {"snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [31, 59]}, {"key": "in-the-united-states", "type": "clause", "offset": [82, 102]}, {"key": "patent-application", "type": "definition", "offset": [158, 176]}, {"key": "claiming-priority", "type": "clause", "offset": [177, 194]}, {"key": "use-of-derivatives", "type": "clause", "offset": [282, 300]}, {"key": "pursuant-to", "type": "definition", "offset": [569, 580]}, {"key": "united-states-patent-and-trademark-office", "type": "clause", "offset": [607, 648]}, {"key": "reference-to", "type": "clause", "offset": [652, 664]}, {"key": "reasonable-action", "type": "clause", "offset": [713, 730]}, {"key": "disclosure-statement", "type": "clause", "offset": [827, 847]}, {"key": "at-the-time", "type": "clause", "offset": [848, 859]}, {"key": "the-patent", "type": "definition", "offset": [934, 944]}, {"key": "patent-no", "type": "clause", "offset": [979, 988]}, {"key": "other-references", "type": "clause", "offset": [1068, 1084]}, {"key": "required-to-be-disclosed", "type": "clause", "offset": [1095, 1119]}, {"key": "a-us", "type": "clause", "offset": [1210, 1215]}, {"key": "section-82", "type": "clause", "offset": [1277, 1288]}], "samples": [{"hash": "5CHyhBLMsf0", "uri": "/contracts/5CHyhBLMsf0#continuing-application", "label": "License Agreement (Entremed Inc)", "score": 18.0, "published": true}, {"hash": "3LRDEexiX79", "uri": "/contracts/3LRDEexiX79#continuing-application", "label": "License Agreement (Entremed Inc)", "score": 18.0, "published": true}], "size": 2, "snippet": "No later than thirty (30) days following the EFFECTIVE DATE, ENTREMED shall file, in the United States and any other country or region possible, a continuing patent application claiming priority to the United States Patent Application 08/102,767 (filed August 6, 1993) claiming the use of derivatives of 2-methoxyestradiol as anti-angiogenesis agents for conditions including ocular neovascularization, wherein the molecule is substituted at the 2 position of the estradiol ring with a) alkoxy groups and b) alkyl esters. ENTREMED shall file a petition to make special pursuant to 37 CFR 1.102 (d) with the United States Patent and Trademark Office in reference to such continuing application, and shall take all reasonable action to accelerate the prosecution of such application(s). ENTREMED shall also submit an Information Disclosure Statement at the time of United States filing of such continuing application which shall inform the Patent Examiner of the existence of U.S. Patent No 6,011,023 (\u2587\u2587\u2587\u2587\u2587 et al.) and U.S. Patent No. 5,643,900 (Fotsis et al.) and all other references which are required to be disclosed pursuant to 37 CFR Section 1.56. ALLERGAN shall pay ENTREMED * Dollars ($*) upon issue of a U.S. patent containing claims substantially as described in this Section 8.2.", "hash": "3233c3a0860f3d2876185fb5762c4330", "id": 5}, {"snippet_links": [{"key": "this-clause", "type": "clause", "offset": [18, 29]}, {"key": "termination-of-this-contract", "type": "clause", "offset": [85, 113]}], "samples": [{"hash": "8vg1s6KXo4Q", "uri": "/contracts/8vg1s6KXo4Q#continuing-application", "label": "Concession Contract for Recovery and Production of Oil and Natural Gas", "score": 26.100730896, "published": true}, {"hash": "cb7kUJgKl29", "uri": "/contracts/cb7kUJgKl29#continuing-application", "label": "Concession Contract for Recovery and Production of Oil and Natural Gas", "score": 22.5441474915, "published": true}], "size": 2, "snippet": "The provisions of this Clause Twenty-Nine will remain effective and must survive the termination of this Contract.", "hash": "9a484e3c131c480331d2d8cf7965e753", "id": 6}, {"snippet_links": [{"key": "the-consideration-shares", "type": "clause", "offset": [3, 27]}, {"key": "subject-to", "type": "clause", "offset": [28, 38]}, {"key": "by-the-purchaser", "type": "clause", "offset": [61, 77]}, {"key": "sold-to", "type": "clause", "offset": [102, 109]}, {"key": "a-third-party", "type": "clause", "offset": [110, 123]}, {"key": "period-of", "type": "clause", "offset": [159, 168]}, {"key": "open-market", "type": "definition", "offset": [221, 232]}, {"key": "date-of", "type": "clause", "offset": [301, 308]}, {"key": "the-offer", "type": "clause", "offset": [309, 318]}, {"key": "provisions-of-this-section", "type": "clause", "offset": [324, 350]}], "samples": [{"hash": "3QzAeFB6LNN", "uri": "/contracts/3QzAeFB6LNN#continuing-application", "label": "Royalty Purchase Agreement", "score": 31.3408622742, "published": true}, {"hash": "31ndOea9prd", "uri": "/contracts/31ndOea9prd#continuing-application", "label": "Royalty Purchase Agreement (International Royalty Corp)", "score": 21.0, "published": true}], "size": 2, "snippet": "If the Consideration Shares subject to an Offer not accepted by the Purchaser or any assignee are not sold to a Third Party under section 2.8(c)(i) within the period of ninety (90) days referred to therein or sold in the open market under section 2.8(c)(ii) within the period of one (1) year from the date of the Offer, the provisions of this section 2.8 shall again apply.", "hash": "8cb2b47fb83118a9618248fec35ca3fe", "id": 7}, {"snippet_links": [{"key": "terms-of-this-agreement", "type": "clause", "offset": [4, 27]}, {"key": "to-apply", "type": "clause", "offset": [42, 50]}, {"key": "employment-with-company", "type": "clause", "offset": [65, 88]}, {"key": "length-of-service", "type": "clause", "offset": [107, 124]}, {"key": "duties-and-responsibilities", "type": "clause", "offset": [171, 198]}, {"key": "other-terms-of-employment", "type": "clause", "offset": [229, 254]}, {"key": "and-the-company", "type": "clause", "offset": [266, 281]}, {"key": "in-writing", "type": "clause", "offset": [298, 308]}], "samples": [{"hash": "dPIytj7YzEh", "uri": "/contracts/dPIytj7YzEh#continuing-application", "label": "Executive Employment Agreement (Aurinia Pharmaceuticals Inc.)", "score": 32.1485290527, "published": true}], "size": 2, "snippet": "The terms of this Agreement will continue to apply throughout my employment with Company, regardless of my length of service or any changes that may occur to my position, duties and responsibilities, compensation or benefits, or other terms of employment, unless me and the Company agree otherwise in writing.", "hash": "f7c14dc045e8310b379d72d05b87ec0a", "id": 8}, {"snippet_links": [{"key": "terms-of-this-agreement", "type": "clause", "offset": [4, 27]}, {"key": "to-apply", "type": "clause", "offset": [42, 50]}, {"key": "length-of-service", "type": "clause", "offset": [124, 141]}, {"key": "to-the-executive", "type": "clause", "offset": [176, 192]}, {"key": "duties-and-responsibilities", "type": "clause", "offset": [205, 232]}, {"key": "other-terms-of-employment", "type": "clause", "offset": [263, 288]}, {"key": "changes-to-the-company", "type": "clause", "offset": [300, 322]}, {"key": "a-reorganization", "type": "clause", "offset": [338, 354]}, {"key": "plan-of-arrangement", "type": "clause", "offset": [356, 375]}, {"key": "merger-or-acquisition", "type": "definition", "offset": [396, 417]}, {"key": "in-writing", "type": "clause", "offset": [465, 475]}, {"key": "without-limiting-the-generality-of-the-foregoing", "type": "clause", "offset": [477, 525]}, {"key": "without-just-cause", "type": "clause", "offset": [566, 584]}, {"key": "the-period", "type": "clause", "offset": [693, 703]}, {"key": "after-termination", "type": "clause", "offset": [704, 721]}], "samples": [{"hash": "21bh6PllMMQ", "uri": "/contracts/21bh6PllMMQ#continuing-application", "label": "Executive Employment Agreement (Lexaria Bioscience Corp.)", "score": 33.0355911255, "published": true}], "size": 2, "snippet": "The terms of this Agreement will continue to apply throughout the Executive\u2019s employment, regardless of:\na) the Executive\u2019s length of service; or\nb) any changes that may occur to the Executive\u2019s position, duties and responsibilities, compensation or benefits, or other terms of employment; or\nc) any changes to the Company as a result of a reorganization, plan of arrangement, reverse take-over, merger or acquisition; unless the Executive and KMSC agree otherwise in writing. Without limiting the generality of the foregoing, Subsection 4.2(Termination by the KMSC Without Just Cause) and Subsection 7.2(Non-Solicitation) will continue to apply throughout the Executive\u2019s employment (and for the period after termination as stated in Subsection 7.2), regardless of his length of service or any changes that may occur to his position, duties and responsibilities, compensation or benefits, or other terms of employment, unless the Executive and KMSC agree otherwise in writing.", "hash": "d344b8dce1405afafa6666f173e39652", "id": 9}, {"snippet_links": [], "samples": [{"hash": "kTOwAwuV6OD", "uri": "/contracts/kTOwAwuV6OD#continuing-application", "label": "Purchase and Sale Agreement (Life Sciences Research Inc)", "score": 18.0, "published": true}], "size": 1, "snippet": "12 11.4 Acknowledgment...........................................13", "hash": "4a3a620f7db9cb13fc5f5b5c277d6877", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih9jb250aW51aW5nLWFwcGxpY2F0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"parents": [["voting", "Voting"], ["general", "General"], ["miscellaneous", "Miscellaneous"], ["personal-service-agreement", "Personal Service Agreement"], ["patents", "Patents"]], "size": 38, "title": "Continuing Application", "children": [], "id": "continuing-application", "related": [["listing-application", "Listing Application", "Listing Application"], ["provisional-application", "Provisional Application", "Provisional Application"], ["general-application", "General Application", "General Application"], ["new-application-for-licensure", "New Application for Licensure", "New Application for Licensure"], ["application-approval", "Application Approval", "Application Approval"]], "related_snippets": [], "updated": "2026-03-21T05:57:23+00:00"}, "json": true, "cursor": ""}}